今开:3.25 | 昨收:3.28 |
最高:3.32 | 最低:3.21 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.70356151E8 |
Atea(AVIR)06-22 06:15
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076400 Size: 7 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074986 Size: 6 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074987 Size: 6 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074989 Size: 6 KB 网页链接查看全文
Atea(AVIR)04-27 04:35
$Atea(AVIR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-049220 Act: 34 Size: 1 MB 网页链接查看全文
Atea(AVIR)06-06 04:05
$Atea(AVIR)$ 144 Report of proposed sale of securities Accession Number: 0001973141-24-000291 Act: 33 Size: 4 KB 网页链接查看全文
Atea(AVIR)06-08 06:45
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-070965 Size: 5 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074988 Size: 6 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074985 Size: 6 KB 网页链接查看全文
Atea(AVIR)06-19 17:26
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074984 Size: 6 KB 网页链接查看全文
智通财经APP获悉,摩根大通分析师Eric Joseph将Atea Pharmaceuticals(AVIR.US)的评级从“增持”下调至“中性”,并将其目标价从61美元下调至16美元。 据悉,Atea Pharmaceuticals周二表示,其研制的AT-527型口服新冠药物未能通过一项关... 网页链接
智通财经APP获悉,美东时间10月19日(周二)盘后,截至发稿,临床阶段生物制药公司Atea Pharmaceuticals(AVIR.US)涨超3%,此前该股收跌65.96%,报13.82美元。据悉,Atea Pharmaceuticals周二表示,其研制的AT-527型口服新冠药物未能通过一... 网页链接
生物制药公司Atea Pharmaceuticals, Inc。(AVIR.O)盘前大涨44%,此前默沙东(MRK.N)及其合作伙伴Ridgeback公布了其治疗新冠病毒药物的中期数据。 网页链接
美国卫生和公共服务部发表声明,美国政府将投资32亿美元开发针对Covid-19的抗病毒药物。 一些药物可能在年底前上市。 政府正在考虑Atea Pharmaceuticals开发的AT-527。 Atea股价周四一度上涨13.6%。 辉瑞科学家... 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076394 Size: 7 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076388 Size: 7 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076400 Size: 7 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076379 Size: 9 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076381 Size: 7 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076363 Size: 7 KB 网页链接
$Atea(AVIR)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-165886 Act: 34 Size: 153 KB 网页链接
$Atea(AVIR)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000924 Act: 33 Size: 4 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074986 Size: 6 KB 网页链接
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-074987 Size: 6 KB 网页链接